Developing new treatments and prevention methods for HIV in children.
Official title: Expertise in Professional Pharmaceutical Project Management
Funded at Advanced Bioscience Laboratories, INC. · NIH-11161812 · Data updated 2026-11-12
This study is all about finding better ways to prevent and treat HIV in kids aged 0-11 by working with experts to create new medicines and strategies that can help them stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2030 |
| Funding year | 2024 |
| Award (this year) | $693,109 |
| NIH project number | 75N93023D00001-0-759302400003-1 |
| Project ID | NIH-11161812 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 0-11 years who are at risk for or affected by HIV/AIDS.
✕Less likely to help
Patients over the age of 11 or those not at risk for HIV/AIDS may not receive benefits from this research.
What this research studies
This research focuses on advancing pediatric HIV prevention and treatment by providing essential resources and support for the development of new therapeutic products. It aims to facilitate the discovery and clinical testing of innovative treatments and prevention strategies, particularly for children aged 0-11 years. The approach includes collaboration with academic and private sector partners to ensure that promising candidate products are efficiently developed and brought to clinical trials. By addressing critical gaps in product development, this research seeks to enhance the availability of effective HIV prevention and treatment options for young patients.
Why it matters
Potential benefit: If successful, this research could lead to new, effective HIV prevention and treatment options specifically designed for children.
How similar studies have gone: Previous research has shown success in developing pediatric treatments for HIV, indicating a promising avenue for further advancements.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Silvera, Peter — Advanced Bioscience Laboratories, INC.
- Study coordinator: Silvera, Peter
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.